|
|
Volumn 16, Issue 9, 2001, Pages 852-857
|
|
Galantamine: A randomized, double-blind, dose comparison in patients with Alzheimer's disease
|
|
Author keywords
Acetylcholinesterase inhibitor; Alzheimer's disease; Dementia; Galantamine
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
GALANTAMINE;
NICOTINIC RECEPTOR;
PLACEBO;
ADULT;
AGED;
ALZHEIMER DISEASE;
APPETITE DISORDER;
ARTICLE;
CLINICAL TRIAL;
COGNITION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
FEMALE;
FOOD DRUG INTERACTION;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
OUTCOMES RESEARCH;
PARALLEL DESIGN;
PSYCHOLOGIC ASSESSMENT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
STATISTICAL ANALYSIS;
SYMPTOM;
VERTIGO;
VOMITING;
AGED;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
COGNITION DISORDERS;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
GALANTAMINE;
HUMANS;
MALE;
MENTAL STATUS SCHEDULE;
TREATMENT OUTCOME;
|
|
EID: 0034810025
PISSN: 08856230
EISSN: None
Source Type: Journal
DOI: 10.1002/gps.409 Document Type: Article |
|
Times cited : (204)
|
|
References (22)
|
